title: Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
authors.affiliation: Department of Dermatology and Allergology, Helsinki University Central Hospital, Finland.|Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
authors.forename: N
authors.initials: N
authors.lastname: Neittaanmäki-Perttu
authors.affiliation: Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Grönroos
authors.affiliation: Department of Dermatology and Allergology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
authors.forename: T T
authors.initials: TT
authors.lastname: Karppinen
authors.affiliation: Department of Pathology, Päijät-Häme Social and Health Care Group, Lahti, Finland.
authors.forename: T T
authors.initials: TT
authors.lastname: Tani
authors.affiliation: Department of Dermatology, Tampere University and Tampere University Hospital, Finland.
authors.forename: E
authors.initials: E
authors.lastname: Snellman
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000369:Aged, 80 and over; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy*; D008297:Male; D009824:Ointments; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D010865:Pilot Projects; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D009824:Ointments; D017319:Photosensitizing Agents; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid; C419924:5-aminolevulinic acid hexyl ester